Mergers expansion Sentec recently expanded through the acquisition of Pulmo Tech, signaling aggressive growth and broader product capabilities in respiratory monitoring and therapy which presents cross-sell opportunities to existing Pulmo Tech customers and potential integration with Sentec's tCOM+ system.

Transcutaneous monitoring The launch of the tCOM+ transcutaneous monitoring system represents a flagship product with modern non-invasive monitoring capabilities, suitable for hospitals and clinics seeking advanced respiratory care solutions and opportunities to upsell to current distributors or care facilities.

Strategic partnerships Past collaborations with Ecologi and engagement in career fair sustainability initiatives indicate a willingness to partner on value-added programs; leverage for joint sustainability projects, grant opportunities, and co-marketing with compliant suppliers to enhance market credibility.

Global reach Swiss-American footprint and worldwide distribution of respiratory care solutions suggest demand across multiple regions; target international hospital systems, rehabilitation centers, and home-care networks looking for accurate non-invasive monitoring and therapy equipment.

Financial health signals Revenue range of 25 to 50 million with mid-size employee base aligns Sentec with niche but scalable players; pursue mid-market procurement cycles, channel partnerships, and service contracts to stabilize recurring revenue and expand after the Pulmo Tech integration.